Literature DB >> 24199544

[Research on situation and countermeasure of Erigeron breviscapus plant production].

Wei Zhang1, Sheng-Chao Yang, Guang-Hui Zhang, Bao Su.   

Abstract

For more than ten years, Erigeron breviscapus has been used for the treatment of cardiovascular and cerebrovascular diseases, it experienced the procedure from wild species to the cultivars, and the quality of drug was rapidly improved. In order to further promote the development of E. breviscapus planting industry, this paper analyzes the development status and existing problems of E. breviscapus planting. Some measures would be come forward, such as strengthen the government's policy support and industrial regulate, accelerate the industry standard and technological innovation, expand brand effect of E. breviscapus of Yunnan, so that the industry has the health and sustainable development.

Entities:  

Mesh:

Year:  2013        PMID: 24199544

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  4 in total

1.  Innovative development path of ethnomedicines: a case study.

Authors:  Zhaoyun Zhu; Yali Gui; Li Wang; Ting Wang; Yang Yang; Yunzhuang Niu; Dehuan Fu; Jingkun Wang; Tao Cui
Journal:  Front Med       Date:  2017-04-19       Impact factor: 4.592

Review 2.  Applications of Yeast Synthetic Biology Geared towards the Production of Biopharmaceuticals.

Authors:  Roy S K Walker; Isak S Pretorius
Journal:  Genes (Basel)       Date:  2018-07-06       Impact factor: 4.096

3.  Engineering the expression of plant secondary metabolites-genistein and scutellarin through an efficient transient production platform in Nicotiana benthamiana L.

Authors:  Xinghao Yao; Kuanyu Wuzhang; Bowen Peng; Tiantian Chen; Yaojie Zhang; Hang Liu; Ling Li; Xueqing Fu; Kexuan Tang
Journal:  Front Plant Sci       Date:  2022-09-06       Impact factor: 6.627

4.  Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches.

Authors:  Xiaonan Liu; Jian Cheng; Guanghui Zhang; Wentao Ding; Lijin Duan; Jing Yang; Ling Kui; Xiaozhi Cheng; Jiangxing Ruan; Wei Fan; Junwen Chen; Guangqiang Long; Yan Zhao; Jing Cai; Wen Wang; Yanhe Ma; Yang Dong; Shengchao Yang; Huifeng Jiang
Journal:  Nat Commun       Date:  2018-01-31       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.